Is NGL Fine-Chem Ltd (NGLFINE) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that NGL Fine-Chem Ltd is a average quality company .

Is NGL Fine-Chem Ltd (NGLFINE) undervalued or overvalued?

The key valuation ratios of NGL Fine-Chem Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is NGL Fine-Chem Ltd (NGLFINE) share price return in the past 10 years?

NGL Fine-Chem Ltd share price has appreciated 25% annually (CAGR) over the past ten years.

Is NGL Fine-Chem Ltd (NGLFINE) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of NGL Fine-Chem Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of NGL Fine-Chem Ltd (NGLFINE)?

Company share prices are keep on changing according to the market conditions. The current trading price of NGL Fine-Chem Ltd (NGLFINE) on 17-Apr-2026 16:59:59 at 16:59 is 2229.75.

What is the P/E ratio of NGL Fine-Chem?

The latest standalone P/E ratio of NGL Fine-Chem as of 17-Apr-2026 is 46.29.

What is the P/B ratio of NGL Fine-Chem Ltd (NGLFINE)?

The latest standalone P/B ratio of NGL Fine-Chem Ltd (NGLFINE) as of 17-Apr-2026 is 4.46.

What is the 52-week high and low of NGL Fine-Chem Ltd (NGLFINE)?

The 52-week high of NGL Fine-Chem Ltd (NGLFINE) is Rs. 2596.00 and the 52-week low is Rs. 985.05.

NGL Fine-Chem Ltd (NGLFINE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: NGL Fine-Chem Ltd (NGLFINE)
Brand: NGL Fine-Chem

NGL Fine-Chem Ltd (NGLFINE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

NGL Fine-Chem Ltd (NGLFINE)

BSE: 524774 NSE: NGLFINE

Key Metrics

Market Cap

₹1,378 Cr.

P/E Ratio

46.29

Price to Book (P/B)

4.46

Price to Sales (P/S)

3.15

EV/EBITDA

24.98

Return on Capital Employed (ROCE)

8.29%

Current Price

₹2,229.8

Return on Equity (ROE)

6.69%

Return on Assets (ROA)

4.66%

Operating Profit Margin

7.4%

Net Profit Margin

5.05%

Gross Profit Margin

9.2%

Book Value per Share

₹499.7

Sales Growth (YoY)

9.22%

Sales Growth (3 Years)

4.08%

Operating Profit Growth (1 Year)

-40.64%

Operating Profit Growth (3 Years)

-26.13%

Net Profit Growth (1 Year)

-52.93%

52-Week Low / High

₹985 / 2,596

Net Profit Growth (3 Years)

-29.73%

Dividend Yield

0.16%

Promoter Holding

72.74%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of NGL Fine-Chem Ltd?

NGL Fine-Chem Ltd revenue growth is 9.2% for FY-2025 , which is below its 5 year CAGR of 18.8% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of NGL Fine-Chem Ltd?

Promoters hold 72.74% of the NGL Fine-Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of NGL Fine-Chem Ltd vs industry peers?

NGL Fine-Chem Ltd revenue CAGR is 18.75% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does NGL Fine-Chem Ltd belong to?

NGL Fine-Chem Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of NGL Fine-Chem Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 24.8% based on the current price.

DeciZen - make an informed investing decision on NGL Fine-Chem

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

NGL Fine-Chem stock performance

Key Ratios

Is NGL Fine-Chem Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	37.1%	33.8%	21.7%	27.6%	13.7%	51.9%	34.7%	11.5%	18.9%	8.3%	-
Value Creation Index ⓘ	1.7	1.4	0.6	1.0	0.0	2.7	1.5	-0.2	0.4	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	96.3	99.7	114	153	152	258	319	275	329	359	437
Sales YoY Gr.	-	3.6%	14%	34.8%	-0.7%	69.7%	23.4%	-13.7%	19.6%	9.2%	-
Adj EPS ⓘ	18.5	22.9	18.6	29	16.6	88.1	84.6	29.4	58.4	26.2	48.2
YoY Gr.	-	24.2%	-18.9%	56%	-42.7%	430%	-4%	-65.2%	98.4%	-55.2%	-
BVPS (₹) ⓘ	71.6	96.2	116.6	149.1	163.8	251.6	334.4	365	425.4	452.6	499.7
Adj Net Profit ⓘ	11.4	14.2	11.5	17.9	10.3	54.5	52.3	18.2	36.1	16.2	30
Cash Flow from Ops. ⓘ	8.4	9.9	22.4	8.9	19.6	26.6	15.8	31.9	11.1	17	-
Debt/CF from Ops. ⓘ	1.7	2.3	1.2	3.1	1.4	0.6	1.9	1	3.1	4.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.8%	18.8%	4.1%	9.2%
Adj EPS ⓘ	4%	9.5%	-32.4%	-55.2%
BVPSⓘ	22.7%	22.5%	10.6%	6.4%
Share Price	25%	5.9%	18.4%	111.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	29.6	27.3	17.5	21.8	10.6	42.4	28.9	8.4	14.8	6	10.1
Op. Profit Mgn % ⓘ	22.8	25.6	19	21.1	15.2	29.8	20.7	10.4	13.6	7.4	10.4
Net Profit Mgn % ⓘ	11.8	14.2	10.1	11.7	6.8	21.1	16.4	6.6	11	4.5	6.8
Debt to Equity ⓘ	0.3	0.4	0.4	0.3	0.3	0.1	0.2	0.1	0.1	0.3	-
Working Cap Days ⓘ	160	187	198	167	184	132	166	216	186	191	106
Cash Conv. Cycle ⓘ	74	81	65	55	79	49	74	99	76	73	52

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	48.2	56.8
TTM Sales (₹ Cr.)	437	447
BVPS (₹) ⓘ	499.7	511.3
Reserves (₹ Cr.) ⓘ	306	313
P/BV ⓘ	4.46	4.36
PE ⓘ	46.29	39.24

From the Market
52 Week Low / High (₹)	985.05 / 2596.00
All Time Low / High (₹)	0.40 / 3789.45
Market Cap (₹ Cr.)	1,378
Equity (₹ Cr.)	3.1
Face Value (₹)	5
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of NGL Fine-Chem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	96	100	114	153	152	258	319	275	329	359
Operating Expenses ⓘ +	74	74	92	121	131	181	253	246	284	333
Manufacturing Costs	13	15	18	22	27	33	50	50	63	69
Material Costs	41	38	46	63	65	103	148	140	155	185
Employee Cost	11	14	18	21	24	27	33	34	41	51
Other Costs ⓘ	10	8	10	15	16	19	22	23	25	28
Operating Profit ⓘ	22	25	22	32	21	77	66	29	45	27
Operating Profit Margin (%)	22.8%	25.5%	19.0%	21.1%	13.7%	29.8%	20.7%	10.4%	13.6%	7.4%
Other Income ⓘ +	0	1	3	4	3	9	13	8	16	10
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	1	2	3	3	2	2	2	2	3
Depreciation ⓘ	3	3	5	6	7	7	8	8	8	9
Profit Before Tax ⓘ	18	23	18	28	14	76	69	27	51	24
Tax ⓘ	6	8	5	7	4	21	17	6	12	6
Profit After Tax	11	15	13	20	11	55	52	20	39	18
PAT Margin (%)	11.8%	14.9%	11.1%	13.1%	7.0%	21.5%	16.4%	7.3%	11.7%	5.1%
Adjusted EPS (₹)	18.5	24.1	20.5	32.6	17.2	89.8	84.6	32.6	62.4	29.4
Dividend Payout Ratio (%)	0%	0%	0%	5%	10%	2%	2%	5%	3%	6%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	44	59	72	92	101	155	207	226	263	280
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	41	56	69	89	98	152	203	222	260	277
Debt +	13	20	24	23	23	11	27	30	32	72
Long Term Debt	0	9	12	8	8	6	3	2	1	25
Short Term Debt	12	11	11	15	15	5	23	28	32	47
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	14	14	24	16	21	27	35	23	47	54
Others Liabilities ⓘ	7	17	14	18	11	12	10	9	11	20
Total Liabilities ⓘ	78	111	133	149	156	206	278	288	353	426
Fixed Assets
Net Fixed Assets ⓘ +	24	25	56	61	61	58	59	59	60	120
Gross Block	38	28	64	74	81	85	92	100	108	177
Accumulated Depreciation	13	3	7	13	20	27	33	41	48	57
CWIP ⓘ	2	16	3	0	0	1	6	26	46	50
Investments ⓘ	3	6	6	9	14	33	32	43	57	63
Inventories	10	12	17	19	28	38	55	27	43	49
Trade Receivables	32	30	28	33	26	38	65	65	83	80
Cash Equivalents	2	2	4	3	3	5	1	13	2	6
Others Assets ⓘ	4	20	19	25	23	34	60	54	63	58
Total Assets ⓘ	78	111	133	149	156	206	278	288	353	426

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	8	10	22	9	20	27	16	32	11	17
PBT ⓘ	18	23	18	28	14	76	69	27	51	24
Adjustment ⓘ	3	3	5	8	11	3	7	6	-1	9
Changes in Working Capital ⓘ	-6	-8	4	-19	-2	-32	-43	6	-26	-10
Tax Paid ⓘ	-6	-8	-5	-7	-4	-21	-17	-6	-12	-6
Cash Flow From Investing Activity ⓘ +	-10	-10	-21	-10	-19	-24	-16	-24	-17	-16
Capex	-10	-18	-23	-14	-7	-5	-14	-29	-28	-73
Net Investments	0	1	0	0	-4	1	0	0	0	0
Others ⓘ	0	7	2	5	-8	-20	-2	5	11	57
Cash Flow From Financing Activity ⓘ +	2	0	0	0	-1	-1	-1	-1	-1	-1
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-1	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	-1	-1	-1	-1	-1	-1
Others ⓘ	3	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0	-0	1	-1	-0	2	-1	7	-7	0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	29.59	28.73	19.22	24.52	10.97	43.22	28.86	9.31	15.78	6.69
ROCE (%)	37.14	33.8	21.68	27.63	13.65	51.9	34.71	11.5	18.93	8.29
Asset Turnover Ratio	1.44	1.13	0.95	1.08	1	1.43	1.32	0.97	1.03	0.92
PAT to CFO Conversion(x)	0.73	0.67	1.69	0.45	1.82	0.49	0.31	1.6	0.28	0.94
Working Capital Days
Receivable Days	103	107	91	72	71	45	59	86	82	83
Inventory Days	39	37	45	42	56	46	53	54	39	47
Payable Days	123	123	145	111	97	74	65	71	83	100

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

NGL Fine-Chem Ltd FAQs

The current trading price of NGL Fine-Chem on 17-Apr-2026 16:59 is ₹2,229.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of NGL Fine-Chem stood at ₹1,377.5 Cr

The latest P/E ratio of NGL Fine-Chem as of 16-Apr-2026 is 46.29.

The latest P/B ratio of NGL Fine-Chem as of 16-Apr-2026 is 4.46.

The 52-week high of NGL Fine-Chem is ₹2,596 and the 52-week low is ₹985.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of NGL Fine-Chem is ₹437 ( Cr.) .

About NGL Fine-Chem Ltd

NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

Animal health
Human health
Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

NGL Fine-Chem Ltd (NGLFINE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

NGL Fine-Chem Share Price